Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:32 PM
Ignite Modification Date:
2025-12-24 @ 7:32 PM
NCT ID:
NCT03873103
Eligibility Criteria:
Inclusion Criteria:
* Patients with metastatic solid tumors that are candidates for systemic therapy (early lines are preferred).
* Patient showing an Eastern Cooperative Oncology Group (ECOG) Performance Status of ≤ 2.
* Patients able to provide written informed consent prior to enrollment into a subsequent clinical trial.
* Patients agrees to provide NGS data (somatic and/or germline) as well as clinical data baseline and during follow-up.
Exclusion Criteria:
* Life expectancy of less than 12 weeks.
* Inability to comply with protocol procedures.
* Known presence of severe hematopoietic, renal, and/or hepatic dysfunction (according to the local PI).
* Targeted gene sequencing on DNA extracted from decalcified bone biopsies is not accepted.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT03873103
Study Brief:
Protocol Section:
NCT03873103